COVID-19 prevention and multiple sclerosis management: The SAFE pathway for the post-peak
File(s)covid-safe_Moccia_2020.pdf (158.32 KB)
Accepted version
Author(s)
Type
Journal Article
Abstract
Background
We hereby report on our experience from Naples (South Italy), where the peak of coronavirus disease 2019 (COVID-19) has already passed.
Methods
Assuming that COVID-19 will be circulating until vaccination and/or herd immunity is achieved (possibly not earlier than 2021), we have developed a protocol for the long-term management of multiple sclerosis (MS).
Results
We have defined a pathway for the access to the MS Centre with logistic, preventative and clinical recommendations, and have also included 14-day self-isolation and COVID-19 testing before some disease modifying treatments.
Discussion
Overall, we believe our experience could be helpful for MS management in the upcoming months.
We hereby report on our experience from Naples (South Italy), where the peak of coronavirus disease 2019 (COVID-19) has already passed.
Methods
Assuming that COVID-19 will be circulating until vaccination and/or herd immunity is achieved (possibly not earlier than 2021), we have developed a protocol for the long-term management of multiple sclerosis (MS).
Results
We have defined a pathway for the access to the MS Centre with logistic, preventative and clinical recommendations, and have also included 14-day self-isolation and COVID-19 testing before some disease modifying treatments.
Discussion
Overall, we believe our experience could be helpful for MS management in the upcoming months.
Date Issued
2020-09
Date Acceptance
2020-06-08
Citation
Multiple Sclerosis and Related Disorders, 2020, 44, pp.1-3
ISSN
2211-0348
Publisher
Elsevier BV
Start Page
1
End Page
3
Journal / Book Title
Multiple Sclerosis and Related Disorders
Volume
44
Copyright Statement
© 2020 Elsevier Ltd. All rights reserved. This manuscript is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Licence http://creativecommons.org/licenses/by-nc-nd/4.0/
Identifier
https://www.sciencedirect.com/science/article/pii/S2211034820303588?via%3Dihub
Subjects
1109 Neurosciences
Publication Status
Published online
Article Number
102282
Date Publish Online
2020-06-10